Damià Tormo Carulla, 2017 Princess of Girona Foundation Business Award

The winner was chosen for combining a brilliant scientific career with being an entrepreneur and investor capable of connecting the world of research with successful entrepreneurial initiative in Spain.

Damià Tormo Carulla (Valencia, 1981) graduated in Biology from the University of Valencia and holds a doctorate in Immunology and Molecular Genetics from Rheinische Friedrich-Wilhelms-Universität Bonn (Germany). He also has an international master’s in Biotechnology Management (MBM) from IE Business School and has spent time as a student and researcher at institutions such as the University of Cambridge (UK), Michigan University (USA) and the Spanish National Cancer Research Centre (CNIO).

He is currently the founder and managing partner of the Columbus Venture Partners fund and founder and Board member of different biotechnology companies that are developing drugs, software, biotechnology services and cosmetics. He is also the founder and general manager of Artax Biopharma, an American company that develops drugs to treat autoimmune diseases. He was the founder and general manager until 2013 (now he is the chairman) of BiOncoTech Therapeutics (Spain), which develops drugs to treat aggressive tumours. Damià Tormo is also chairman and founder of the Columbus Foundation, which facilitates access to the most advanced and effective therapies for children with cancer or rare diseases in order to improve their life expectancy and quality of life.

Copyright © 2019 Princess of Girona Foundation
C. Juli Garreta, 1, 1r E   17002 Girona   (Spain)
Tel. 34 972 410 410   Fax 34 972 410 400   info@fpdgi.org